Fractyl Health, Inc. (GUTS) vs Tenax Therapeutics, Inc. (TENX)

Fractyl Health, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Fractyl Health, Inc. and Tenax Therapeutics, Inc. are of similar size ($56.5M and $55.2M). Fractyl Health, Inc. grew revenue faster over the last twelve months: −22.5% against −70.8%. Across the 12 metrics below, Fractyl Health, Inc. leads on 8 and Tenax Therapeutics, Inc. on 4.

Valuation

Metric GUTS TENX Biotechnology median
P/E n/m n/m 8.50
P/S 2,644.15 201.11 9.71
P/B n/m 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.71 0.64
EV/Sales 2,464.64 (141.75) 9.21
Earnings yield (56.77%) (108.82%) (33.15%)
Free cash flow yield (33.75%) (66.58%) (25.50%)

Profitability

Metric GUTS TENX Biotechnology median
Gross margin 46.24% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% (59.80%) (56.36%)
Return on assets (146.75%) (57.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS TENX Biotechnology median
Revenue growth (TTM) (22.50%) (70.77%) 6.02%
EPS growth (last fiscal year) (14.81%) (16.52%) 30.26%
Revenue growth, 5-year CAGR — 0.79% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS TENX Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 15.07 4.72
Net debt to EBITDA 0.53 1.73 0.96

Dividend

Metric GUTS TENX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GUTS TENX Biotechnology median
Market cap 55.18m 56.51m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack